《新股消息》芯片激光雷達生產商Robosense Technology申赴港上市
芯片激光雷達生產商Robosense Technology遞表申請上市,摩根大通及華興資本為聯席保薦人。招股文件顯示,Robosense Technology上市前投資者包括阿里-SW(09988.HK)及旗下菜鳥共同持有11.03%股權。
公司去年收入按年增60%至約5.3億元人民幣(下同);虧損增加26%至20.9億元;撇除股份基礎薪酬、金融工具公允價值變動及上市開支後,經調整虧損按年擴大4倍至5.6億元。
公司預期籌集資本中的45%將用於研發,持續建立並優化產品管線及團隊擴展以支持公司計劃,包括於升級和迭代在固態激光雷達平台上現有的激光雷達產品等;提升製造、測試及驗證能力及加強銷售營銷則各佔20%等。5%將作戰略合作。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.